Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of Hexaxim in Vietnamese Infants
NCT02428491Phase 3Completed
- Sponsor
- Sanofi
- Start
- Apr 2015
- Primary completion
- Jan 2017
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of hexaxim in diphtheria, Tetanus, pertussis, poliomyelitis, hepatitis B (HBV), sponsored by Sanofi. Started Apr 2015; status: completed.
02
Drugs
hexaxim
03
Conditions
diphtheriaTetanuspertussispoliomyelitishepatitis B (HBV)
Beyond the preview
Go deeper on NCT02428491.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02428491.